- Activity pressure is positive on the latest completed week.
OPRX
NASDAQ
Week ended 24 Jul 2026
Weekly Investor Report
OPTIMIZERx Corp · Healthcare · Health Information Services
Latest close
6.24 USD
-6.7%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -15.8% below the Trend Line and sits at 9.6% of its 52-week range. The latest completed week returned -6.7%, after a 21.9% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers. Options positioning is mixed with 25/100 conviction, while the latest news-sentiment score is 61/100. Near-term considerations: volume confirmation is below normal; earnings are due in 7d.
Setup score
33
out of 100
Latest Close
6.24 USD
24 Jul 2026
1W Return
-6.7%
latest completed week
4W Return
21.9%
short-term follow-through
12W Return
-6.9%
quarterly tape
Trend Breadth
32.7%
17 of 52 weeks active
Volume Ratio
0.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 44.16% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-6.7%
Latest completed week; four-week move 21.9%.
Indicator stack
18/83
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 44.16%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
Options pressure
Mixed
25/100 conviction; expected move 31.5%.
News sentiment
61/100
41 relevant articles in the latest sentiment read.
Event risk
7d
Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -15.8% below the Trend Line and sits at 9.6% of its 52-week range. The latest completed week returned -6.7%, after a 21.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1112-week average 0.04
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.11Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 21.9% over four weeks, -6.9% over 12 weeks, and -56.5% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year17
Trend breadth32.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.85Latest activity-pressure read.
Pressure change225.8%Four-week change in activity pressure.
Leadership-50.85Latest relative-leadership reading.
RS change19.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers.
Factor week 26 Jul 2026
Financial statements through 31 Dec 2025
Field coverage 94%
Model confidence 90%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength82/100Blend of value, momentum, and quality. Underlying universe rank 19; rank 1 is best.
Value90/100Relative valuation strength. Underlying universe rank 11; rank 1 is best.
Quality83/100Profitability and accounting quality. Underlying universe rank 18; rank 1 is best.
Momentum3/100Medium-term price momentum. Underlying universe rank 98; rank 1 is best.
Growth74/100Revenue and earnings growth. Underlying universe rank 27; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework90/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 17.1x Price divided by trailing earnings.
- Price / sales
- 1.1x Market value relative to trailing revenue.
- EV / EBITDA
- 6.4x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 12.0% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 69.0% Gross profit retained from each unit of revenue.
- Operating margin
- 13.7% Operating profit retained from revenue.
- Free-cash-flow margin
- 13.4% Free cash flow generated from revenue.
- Return on invested capital
- 7.9% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 13.8% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 107.4% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 7/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.2x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningMixed
OPRX shows mixed options pressure with a 25/100 conviction score, put-call volume ratio of n/a, expected move of 31.5%, and Sharemaestro trend signal inactive.
Conviction25/100
Expected move31.5%
Put/call volume
Insider activity7 / 3
7 acquisitions and 3 disposals in the latest 180-day insider tape.
Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.News sentiment61/100
Weighted news tone is neutral across 41 relevant articles.
22 positive · 15 neutral · 4 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings7dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move31.5%Nearest-chain priced movement where available.
52-week drawdown-72.0%Distance below the 52-week high.
13-week volatility8.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher10 of 2616 weeks finished lower.
Best week+20.9%Week of 3 Jul.
Worst week-19.7%Week of 13 Feb.
Latest week-6.7%Week of 24 Jul.
Shape of recent returns
Strong gains6
Modest gains4
Flat weeks0
Modest losses3
Sharp losses13
Recent vol8.8%13-week weekly-return volatility.
Base vol9.9%52-week weekly-return volatility.
Up/down split21/31Count of positive and negative weeks in the 52-week window.
Average skew7.6% / -7.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Healthcare
4-week rank- / 100
Group average1.3%
Trend breadth51.0%
Trend51.0%active weekly trend signals
MD75.0%positive activity pressure
RS48.0%positive relative leadership
Four-week leaders
IndustryUS Health Information Services
4-week rank5 / 42
Group average1.1%
Trend breadth45.2%
Trend45.2%active weekly trend signals
MD81.0%positive activity pressure
RS31.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape26/100
Trend, activity pressure, participation, and risk combine to a 26/100 tape read.
Indicator analysis24/100Latest 12-week confirmation: trend 0/12, activity pressure 8/12, relative leadership 0/12.
Activity pressure 0.11; No reversal markers Next-Week ExpectancyNegative 44.16%Next-week expectancy is negative with a 44.16% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors66/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 59; Small Cap Core rank 21 SVQF90/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 70.0 of 726 Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Options42/100OPRX shows mixed options pressure with a 25/100 conviction score, put-call volume ratio of n/a, expected move of 31.5%, and Sharemaestro trend signal inactive.
Mixed · Options-market disagreement · Expected move 31.5% Sentiment61/100Weighted news tone is neutral across 41 relevant articles.
OptimizeRx Corp (OPRX) Shareholder Structure: Major Shareholders & Institutional Holdings Insiders7 / 37 acquisitions and 3 disposals in the latest 180-day insider tape.
Earnings7dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 6.24 USD | -6.7% | 7.41 USD | 10.23 USD | 0.85 | -50.85 | 1.1M | Off |
| 17 Jul 2026 | 6.69 USD | 4.4% | 7.62 USD | 10.28 USD | 0.86 | -49.01 | 1.3M | Off |
| 10 Jul 2026 | 6.41 USD | 3.6% | 7.85 USD | 10.32 USD | 0.63 | -53.81 | 1.7M | Off |
| 3 Jul 2026 | 6.19 USD | 20.9% | 8.08 USD | 10.38 USD | 0.44 | -55.23 | 2.0M | Off |
| 26 Jun 2026 | 5.12 USD | 2.8% | 8.35 USD | 10.43 USD | 0.26 | -63.21 | 4.3M | Off |
| 19 Jun 2026 | 4.98 USD | -4.8% | 8.68 USD | 10.49 USD | 0.06 | -66.41 | 1.3M | Off |
| 12 Jun 2026 | 5.23 USD | 2.3% | 9.00 USD | 10.55 USD | 0.01 | -64.39 | 1.3M | Off |
| 5 Jun 2026 | 5.11 USD | -1.5% | 9.34 USD | 10.61 USD | 0.02 | -65.06 | 1.8M | Off |
| 29 May 2026 | 5.19 USD | 5.1% | 9.69 USD | 10.67 USD | -0.04 | -66.74 | 1.5M | Off |
| 22 May 2026 | 4.94 USD | -5.2% | 10.20 USD | 10.73 USD | -0.09 | -67.91 | 2.5M | Off |
| 15 May 2026 | 5.21 USD | -19.1% | 10.76 USD | 10.79 USD | -0.21 | -66.23 | 4.9M | Off |
| 8 May 2026 | 6.44 USD | -3.9% | 11.23 USD | 10.83 USD | -0.44 | -58.93 | 1.6M | Off |
| 1 May 2026 | 6.70 USD | 4.2% | 11.62 USD | 10.87 USD | -0.67 | -55.36 | 1.9M | Off |
| 24 Apr 2026 | 6.43 USD | -10.3% | 12.02 USD | 10.92 USD | -0.93 | -56.90 | 2.4M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.